For research use only. Not for therapeutic Use.
Fenoterol hydrobromide(CAT: I000002) is a selective β2-adrenergic receptor agonist primarily used as a bronchodilator for the treatment of asthma, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. By stimulating β2-adrenergic receptors in the bronchial smooth muscle, Fenoterol induces muscle relaxation and airway dilation, facilitating easier breathing. It also exhibits mild activity on β1-adrenergic receptors, which can lead to cardiovascular side effects at higher doses. Fenoterol hydrobromide is valuable in respiratory research for studying airway hyperresponsiveness and the development of targeted therapies for bronchoconstrictive disorders.
Catalog Number | I000002 |
CAS Number | 1944-12-3 |
Synonyms | Phenoterol |
Molecular Formula | C17H21NO4 • HBr |
Purity | ≥95% |
Target | Neuronal Signaling |
Solubility | DMSO:≥ 38 mg/mL |
Storage | -20°C |
IUPAC Name | 5-[1-hydroxy-2-[1-(4-hydroxyphenyl)propan-2-ylamino]ethyl]benzene-1,3-diol;hydrobromide |
InChI | InChI=1S/C17H21NO4.BrH/c1-11(6-12-2-4-14(19)5-3-12)18-10-17(22)13-7-15(20)9-16(21)8-13;/h2-5,7-9,11,17-22H,6,10H2,1H3;1H |
InChIKey | SGZRQMALQBXAIQ-UHFFFAOYSA-N |
SMILES | CC(CC1=CC=C(C=C1)O)NCC(C2=CC(=CC(=C2)O)O)O.Br |